Skip to content
healthcare.dev

Miglustat

NDC 70710-2039, Miglustat, capsule, from Zydus Pharmaceuticals USA Inc..

Product NDC
70710-2039
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219111
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2039 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MIGLUSTAT100 mg/1

Pharmacologic classes

Enzyme Stabilizer [EPC]; Enzyme Stabilizers [MoA]; Glucosylceramide Synthase Inhibitor [EPC]; Glucosylceramide Synthase Inhibitors [MoA]

Package NDCNDC-11Package
70710-2039-8707102039086 BLISTER PACK in 1 CARTON (70710-2039-8) / 15 CAPSULE in 1 BLISTER PACK (70710-2039-4)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b54cc8a0-2284-44c3-a8fa-d8aaa87a67c6

Use it

Look up 70710-2039 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2039 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-2039. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.